Search and Filter
Results per Page:
Finding a new way to break the supply chain fueling advanced prostate cancer
Fred Hutch researcher wins a $1M grant for a London-Seattle collaboration to find new therapies for drug-resistant prostate cancer
Bottleneck breakthrough
Fred Hutch researchers discover why some HIV-1 variants are more transmissible than others, which could generate new approaches to stop the virus that causes AIDS at cell entry
Making the most of a small supply
Fred Hutch researchers receive $1.3 million grant from the U.S. Department of Defense to study the fundamental biology of five rare liver cancers that could lead to new treatments one day
Priming the pump for future funding
Fred Hutch postdoctoral researchers win NIH training fellowship for pancreatic cancer and kinetochore projects
A quarter century of lifesaving discoveries in prostate cancer
Pacific Northwest Prostate Cancer SPORE insights have transformed patient care and understanding of prostate cancer biology, supported drug discovery worldwide
Finding a rare bile duct cancer’s weaknesses
DOD and Cholangiocarcinoma Foundation awards will help Dr. Debraj Boila reveal genetics, drug targets of intrahepatic cholangiocarcinoma
More to brain tumors than meets the eye
Fred Hutch researchers find new way to classify tumors based on their underlying biology rather than how they look
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Fred Hutch and UW hematology/oncology fellows win ASCO Young Investigator Awards
Winners represent broad range of research
Mapping a pathway to hope
How Fred Hutch researchers revealed the biology behind a drug’s success in a rare liver cancer and paired it with another drug for a one-two punch
Tackling an aggressive form of pancreatic cancer
Dr. Stephanie Dobersch awarded American Cancer Society Fellowship to study genetics of basal pancreatic adenocarcinoma
Bridging the gap between cancer drug target and cancer drug
Fred Hutch RNA-translation expert Dr. Andrew Hsieh receives Harrington Scholar-Innovator Award to develop experimental compound into anti-cancer drug
Targeted new approach and computational tools reveal lung cancer subtypes hiding in patterns in cell-free DNA
Innovative strategy a step toward liquid biopsy to detect, monitor aggressive small cell lung cancer
Revealing how cancer cells cooperate — and how to stop them
$1 million from Kleberg Foundation will support Dr. Kevin Cheung’s investigations into the collaborative strategies tumors use to spread and resist treatment
New techniques, collaborations push patient-focused precision oncology forward
$5.4M NCI award supports Dr. Chris Kemp’s multi-disciplinary discovery platform for cancer-therapy targets
New projects advance health equity research
Two $1M grants support efforts to pinpoint novel prostate cancer biomarkers, improve clinical trial enrollment and inclusion
Extending efficacy for CAR T-cell therapies
Dr. Shivani Srivastava receives NCI MERIT Award to investigate how to improve engineered cancer immunotherapies against solid tumors through reservoirs of self-renewing immune cells
New technique could help make precision medicine more widely available
Simple CUT&Tag adaptation gives information about genetic regulatory elements in formalin-fixed tumor samples
RNA stability may play a role in prostate cancer
New research links mutations in RNA region that helps regulate protein production to progression and drug resistance
Dr. Sita Kugel receives V Foundation Translational Research Award
Grant makes possible a clinical trial of targeted treatment for pancreatic cancer